Legal actions intended to derail the IRA drug price negotiation provision appear to be hitting a dead end. Time will tell if future appeals and challenges are successful.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,